10/06/2015 - 11:41am

With its new status, PTCB will be able to participate in FIP working groups, nominations calls and other efforts while being included in the company’s dialogues and communications. 

10/05/2015 - 1:42pm

The rebranding is part of changes, including new products, that the company says are forthcoming, according to QS/1 president Tammy Devine.

10/05/2015 - 1:33pm

So far in 2015, there have bee 221,200 new cases of lung cancer and 158,040 deaths from the illness, according to the National Cancer Institute.

10/05/2015 - 1:12pm

In a contribution to PhRMA’s conversation about preparedness month, NACDS’s Kathleen Jaeger touts the important role community pharmacies can play in disaster preparedness and the need for its role to grow. 

10/05/2015 - 12:43pm

The Generic Pharceutical Association’s CEO and President Chip Davis offered his recommendations for the Trans-Pacific Partnership. 

10/05/2015 - 12:40pm

The New York Times outlines the impact price increases of Valeant Pharmaceutical's Cuprimine has on one family, juxtaposing Valeant's pharmaceutical business model against the threat of government action. “Cuprimine is just one of many Valeant drugs whose prices have spiked as part of the company’s concerted strategy, which has richly rewarded its investors and made it one of Wall Street’s most popular health stocks,” the article said. “But Valeant’s habit of buying up existing drugs and raising prices aggressively, rather than trying to develop new drugs, has also drawn the ire of lawmakers and helped stoke public outrage against the growing trend of higher and higher drug prices imposed by big drug companies.” (New York Times)



10/05/2015 - 12:22pm

Overall, 22% of consumers who are enabling their health management through technology in 2015 vs. 13% two years ago.

10/05/2015 - 11:36am

Jason Ausili joined NACDS this week as the director of pharmacy affairs. Ausili will drive NACDS' initiatives designed to optimize pharmacy care and will assist with emerging care models.

10/05/2015 - 8:00am

Two Dutch pharmacy associations have presented a plan suggesting that widespread pharmacogenomics might be available by 2020.